NCT06792955View on ClinicalTrials.gov

The Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection Solution

PHASE1CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

June 6, 2025

Study Completion Date

June 6, 2025

Conditions

Overweight/Obesity

Interventions

DRUG

HRS9531 injection

Multi-dose pen of HRS9531 injection solution.

DRUG

HRS9531 injection

Single-dose pen of HRS9531 injection solution.

Trial Locations (1)

250013

Central Hospital Affiliated To Shandong First Medical University, Jinan

All Listed Sponsors

lead

Fujian Shengdi Pharmaceutical Co., Ltd.

INDUSTRY

NCT06792955 - The Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection Solution | Biotech Hunter | Biotech Hunter